Johnson & Johnson (JNJ) Change in Accured Expenses (2009 - 2026)

Johnson & Johnson has reported Change in Accured Expenses for 18 years, with the latest figure at $2.3 billion in Q2 2026.

• Quarterly Change in Accured Expenses rose 297.77% year-over-year to $2.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.4 billion (down 10.91% YoY) and the FY2025 annual result came in at -$5.7 billion, down 451.45% from the prior year.
• Change in Accured Expenses grew to $2.3 billion in Q2 2026 per JNJ's latest filing, from -$3.9 billion in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $6.3 billion in Q2 2023 and troughed at -$6.5 billion in Q1 2025.
• A 5-year average of -$184.2 million and a median of -$427.5 million in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses jumped 8217.07% in 2023, then sank 162.14% in 2025.
• Over 5 years, Change in Accured Expenses stood at -$2.8 billion in 2022, then jumped by 218.14% to $3.3 billion in 2023, then plunged by 132.81% to -$1.1 billion in 2024, then jumped by 145.7% to $499.0 million in 2025, then soared by 364.73% to $2.3 billion in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $2.3 billion, -$3.9 billion, and $499.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.